Evidence map›Paper›PMID 33755267›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2021

Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy.

Koji Takahashi, Mina Yamashita, Tomoki Sakaue, Daijiro Enomoto, Shigeki Uemura, Takafumi Okura, Shuntaro Ikeda, Masafumi Takemoto, Yutaka Utsunomiya, Takashi Hyodo

Open access · goldAbstract readCase Reports
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Koji TakahashiDepartment of Community Emergency Medicine, Ehime University Graduate School of Medicine, Ehime, Japan.ORCID 0000-0003-3826-3941
Mina YamashitaDepartment of Cardiology, Yawatahama City General Hospital, Ehime, Japan.
Tomoki SakaueDepartment of Community Emergency Medicine, Ehime University Graduate School of Medicine, Ehime, Japan.
Daijiro EnomotoDepartment of Cardiology, Yawatahama City General Hospital, Ehime, Japan.
Shigeki UemuraDepartment of Cardiology, Yawatahama City General Hospital, Ehime, Japan.
Takafumi OkuraDepartment of Cardiology, Yawatahama City General Hospital, Ehime, Japan.
Shuntaro IkedaDepartment of Community Emergency Medicine, Ehime University Graduate School of Medicine, Ehime, Japan.
Masafumi TakemotoDepartment of Medical Engineering, Yawatahama City General Hospital, Ehime, Japan.
Yutaka UtsunomiyaDepartment of Medical Engineering, Yawatahama City General Hospital, Ehime, Japan.
Takashi HyodoDepartment of Medical Engineering, Yawatahama City General Hospital, Ehime, Japan.
Yawata Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An elderly Japanese woman developed acute decompensated heart failure caused by persistent atrial fibrillation (AF) and left ventricular systolic dysfunction. Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of AF, electrocardiograms revealed a prolonged QT interval associated with torsade de pointes (TdP). The amiodarone-induced TdP disappeared after intravenous administration of landiolol plus magnesium and potassium, without discontinuation of amiodarone or overdrive cardiac pacing, although the prolonged QT interval persisted. To the best of our knowledge, this is the first report that landiolol could be effective for amiodarone-induced TdP.

Indexed as

AmiodaroneAtrial FibrillationCardiomyopathiesTorsades de PointesAgedAnti-Arrhythmia AgentsElectrocardiographyFemaleHumansMorpholinesUreaAmiodaroneAnti-Arrhythmia AgentslandiololMorpholinesUreaamiodaroneatrial fibrillationheart failurelandiolollong QT syndrometorsade de pointes

Identifiers

PMID33755267
PMCPMC8588365
OpenAlexW3139410866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.